Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | S100B | P04271 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.36 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.35 |
| ▸ | NQO2 | P16083 | 1/20 | 0.34 |
| ▸ | PGK1 | P00558 | 1/20 | 0.34 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.34 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | TNF | P01375 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29600727 | 0.85 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2KDM4EGLAHPGD | |
| SCHEMBL571871 | 0.85 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2KDM4EGLAHPGD | |
| SCHEMBL30690930 | 0.80 | HDAC6 (0.37) | ALDH1A1SMN1; SMN2KDM4EGLAHPGD | |
| SCHEMBL21523292 | 0.79 | HDAC6 (0.39) | ALDH1A1SMN1; SMN2KDM4EGLAHPGD | |
| SCHEMBL29751992 | 0.76 | HDAC6 (0.44) | ALDH1A1KDM4EMAPTMAPK1HDAC6 | |
| SCHEMBL10808625 | 0.75 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2KDM4EGLAHPGD | |
| SCHEMBL10808616 | 0.75 | KDM4E (0.41) | ALDH1A1SMN1; SMN2KDM4EGLAHPGD | |
| SCHEMBL10479158 | 0.73 | MAPT (0.52) | ALDH1A1SMN1; SMN2KDM4EGLAHPGD | |
| SCHEMBL2210085 | 0.72 | MAPT (0.51) | ALDH1A1SMN1; SMN2KDM4EGLAHPGD | |
| SCHEMBL29600466 | 0.72 | MAPT (0.51) | ALDH1A1SMN1; SMN2KDM4EGLAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11192854-B2 | Method for producing semicarbazide compound | TOKUYAMA CORPORATION (JP) | 2021-12-07 | — | — | US | claimed |
| US-11946910-B2 | Triazolinedione adduct, method for producing triazolinedione adduct, method for producing ene compound, and method for analyzing ene compound | TOKUYAMA CORPORATION (JP) | 2024-04-02 | — | — | US | disclosed |
| US-11192854-B2 | Method for producing semicarbazide compound | TOKUYAMA CORPORATION (JP) | 2021-12-07 | — | — | US | disclosed |
| US-20210253587-A1 | TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING ENE COMPOUND, AND METHOD FOR ANALYZING ENE COMPOUND | TOKUYAMA CORPORATION (JP) | 2021-08-19 | — | — | US | disclosed |
| EP-3808750-A1 | TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING ENE COMPOUND, AND METHOD FOR ANALYZING ENE COMPOUND | Tokuyama Corporation (JP) | 2021-04-21 | — | — | EP | disclosed |
| US-20210002212-A1 | METHOD FOR PRODUCING SEMICARBAZIDE COMPOUND | TOKUYAMA CORPORATION (JP) | 2021-01-07 | — | — | US | disclosed |
| EP-3708562-A1 | METHOD FOR PRODUCING SEMICARBAZIDE COMPOUND | Tokuyama Corporation (JP) | 2020-09-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11946910-B2 | Triazolinedione adduct, method for producing triazolinedione adduct, method for producing ene compound, and method for analyzing ene compound | NR2E1, AR, NR5A2 | ALDH1A1 219/4885SMN1; SMN2 4452/4885KDM4E 1814/4885 |
| US-11192854-B2 | Method for producing semicarbazide compound | SALL4, SHH, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | ALDH1A1 900/4885SMN1; SMN2 2747/4885KDM4E 2515/4885 |
| US-20210253587-A1 | TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING ENE COMPOUND, AND METHOD FOR ANALYZING ENE COMPOUND | NR2E1, AR, NR5A2 | ALDH1A1 219/4885SMN1; SMN2 4452/4885KDM4E 1814/4885 |
| US-20210002212-A1 | METHOD FOR PRODUCING SEMICARBAZIDE COMPOUND | SALL4, SHH, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | ALDH1A1 900/4885SMN1; SMN2 2747/4885KDM4E 2515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.